PMID: 373786Jan 1, 1979Paper

Fenoterol in asthma

British Journal of Diseases of the Chest
G AndersonA G Jariwalla


Fenoterol is a beta 2-sympathomimetic bronchodilator. In a double-blind cross-over trial in 17 asthmatic patients with reversible airway obstruction inhalation of both fenoterol (0.4 mg) and terbutaline (0.5 mg) produced a statistically significant greater increase in peak expiratory flow rate than did placebo. The magnitude and duration of response to fenoterol exceeded that to terbutaline in the doses used. The patients' subjective assessment also suggested the relief of their symptoms with the active drugs. Side effects were minimal.


Mar 1, 1984·The Journal of Allergy and Clinical Immunology·C H FeldmanW J Davis
Jan 1, 1982·Pharmacology & Therapeutics·A E Tattersfield
Aug 1, 1983·Postgraduate Medical Journal·B Hockley, N M Johnson
Nov 1, 1990·Perception & Psychophysics·M A Heller, J M Kennedy

Related Concepts

Clinical Trials
Double-Blind Method
Fenoterol Hydrobromide
Peak Expiratory Flow Rate Measurement
Terbutalin von ct

Related Feeds


This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.